VOYA Investment Management
VRNA

VOYA Investment Management’s Verona Pharma VRNA Stock Holding History

VOYA Investment Management’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-57,505
Closed -$5.44M – 2653
2025
Q2 		$5.44M Hold
57,505
– – 0.01% 927
2025
Q1 		$3.65M Sell
57,505
-2,155
-4% -$129K ﹤0.01% 1070
2024
Q4 		$2.77M Sell
59,660
-14,835
-20% -$557K ﹤0.01% 1175
2024
Q3 		$2.14M Buy
74,495
+51,245
+220% +$1.26M ﹤0.01% 1313
2024
Q2 		$336K Buy
23,250
+7,280
+46% +$106K ﹤0.01% 2206
2024
Q1 		$257K Hold
15,970
– – ﹤0.01% 2334
2023
Q4 		$317K Hold
15,970
– – ﹤0.01% 2315
2023
Q3 		$260K Hold
15,970
– – ﹤0.01% 2386
2023
Q2 		$338K Sell
15,970
-35,865
-69% -$765K ﹤0.01% 2300
2023
Q1 		$1.04M Buy
51,835
+30,455
+142% +$658K ﹤0.01% 1628
2022
Q4 		$559K Buy
+21,380
New +$285K ﹤0.01% 1974

Other funds holding VRNA

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VOYA Investment Management's VRNA Position: Q3 2025 in Review

VOYA Investment Management sold out of Verona Pharma (VRNA) in Q3 2025, closing a stake of 57,505 shares — an estimated $5.44M sold.

VOYA Investment Management first reported a position in VRNA in Q4 2022 and held it in 11 quarters. The position peaked at $5.44M in Q2 2025. 243 funds tracked by Wall St. Rank hold VRNA as of Q3 2025.

  • VOYA Investment Management reported no remaining Verona Pharma position as of Q3 2025 after selling out during the quarter.
  • VOYA Investment Management sold 57,505 Verona Pharma shares in Q3 2025, an estimated $5.44M.
  • VOYA Investment Management first reported a position in Verona Pharma in Q4 2022 and held it in 11 quarters.
  • VOYA Investment Management's Verona Pharma position peaked at $5.44M in Q2 2025.
  • 243 funds tracked by Wall St. Rank held Verona Pharma as of Q3 2025.

Based on VOYA Investment Management's 13F filing for Q3 2025, filed 9 Oct 2025.